logo
Book a meeting
Optilume BPH

Optilume Bph

Other, 2495 Xenium Lane N, Plymouth, Minnesota, 55441, United States, 1-10 Employees

urotronic.com

  • twitter
  • LinkedIn

phone no Phone Number: +17*********

Who is OPTILUME BPH

The Optilume drug-coated balloon technology provides a minimally invasive treatment option for men suffering from urinary tract conditions like urethral strictures and benign prostatic hy...

Read More

lock icon Get Full Access
map
  • 2495 Xenium Lane N, Plymouth, Minnesota, 55441, United States Headquarters: 2495 Xenium Lane N, Plymouth, Minnesota, 55441, United States
  • 2015 Date Founded: 2015
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Other

SIC SIC Code: 3841 | NAICS Code: 339112 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from OPTILUME BPH

Optilume BPH Org Chart and Mapping

Employees
Mackenzie Ree

Mackenzie Ree

Manager of Analytical Chemistry

CCRP Jill Moland

CCRP Jill Moland

Clinical Program Director

See Full Org Chart arrow
email-formate-icon
View Email Formats for Optilume BPH
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Optilume BPH

Answer: Optilume BPH's headquarters are located at 2495 Xenium Lane N, Plymouth, Minnesota, 55441, United States

Answer: Optilume BPH's phone number is +17*********

Answer: Optilume BPH's official website is https://urotronic.com

Answer: Optilume BPH's revenue is $1 Million to $5 Million

Answer: Optilume BPH's SIC: 3841

Answer: Optilume BPH's NAICS: 339112

Answer: Optilume BPH has 1-10 employees

Answer: Optilume BPH is in Other

Answer: Optilume BPH contact info: Phone number: +17********* Website: https://urotronic.com

Answer: The Optilume drug-coated balloon technology provides a minimally invasive treatment option for men suffering from urinary tract conditions like urethral strictures and benign prostatic hyperplasia (BPH). BPH affects 70% of men 60-69 years of age and 80% of those 70 years of age or older. The drug-coated balloon technology creates a paradigm change from the methods currently used by urologists to treat these conditions.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access